Cephalon Is Not Sleeping On Moving Patients From Provigil To Nuvigil

Cephalon's plans to protect its billion-dollar wakefulness franchise from the impact of generic competition to Provigil centers on switching patients to a second-generation drug, Nuvigil, with expanded indications